➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Harvard Business School
Boehringer Ingelheim
Mallinckrodt
Moodys

Last Updated: October 22, 2021

DrugPatentWatch Database Preview

Patent: 9,541,560

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 9,541,560
Title:Serological markers of inflammatory bowel disease phenotype and disease progression
Abstract: Disclosed are novel biomarkers and methods related to diagnostic tests for the detection and characterization of inflammatory bowel diseases, such as Crohn\'s disease and ulcerative colitis. In particular, the instant invention relates to novel biomarkers and methods of using such biomarkers to predict disease behavior and severity, to differentiate among disease types, and to optimize selection of treatment options in individuals suspected of having an inflammatory bowel disease.
Inventor(s): Denson; Lee (Wyoming, OH), Trapnel; Bruce Colston (Hamilton, OH), Uchida; Kanji (Tokyo, JP)
Assignee: Children\'s Hospital Medical Center (Cincinnati, OH)
Application Number:14/686,628
Patent Claims:see list of patent claims

Details for Patent 9,541,560

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Partner Therapeutics, Inc. LEUKINE sargramostim For Injection 103362 1991-03-05 ⤷  Free Forever Trial 2027-03-30
Partner Therapeutics, Inc. LEUKINE sargramostim Injection 103362 1991-03-05 ⤷  Free Forever Trial 2027-03-30
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
AstraZeneca
Merck
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.